
Elite Pharmaceuticals (($ELTP)) has held its Q2 earnings call. Read on for the main highlights of the call. Elite Pharmaceuticals’ earnings call carried a predominantly optimistic tone, led by 10%
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ELTP | Elite Pharmaceuticals | 0.37 | -0.22 | -37.01% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.37 | -37.01% |

Elite Pharmaceuticals (($ELTP)) has held its Q2 earnings call. Read on for the main highlights of the call. Elite Pharmaceuticals’ earnings call carried a predominantly optimistic tone, led by 10%

Elite Pharmaceuticals ( ($ELTP) ) has shared an update. On November 12, 2026, Elite Pharmaceuticals reported fiscal 2027 second-quarter results for the three months ended September 30, 2026. Revenue was

Elite Pharmaceuticals ( ($ELTP) ) has shared an update. On November 10, 2026, Elite Pharmaceuticals announced that it would release financial results for the second quarter of fiscal 2027 on

An update from Elite Pharmaceuticals ( ($ELTP) ) is now available. On October 28, 2026, Elite’s board increased its size from four to six directors and unanimously elected Aqeel A.

Elite Pharmaceuticals (($ELTP)) has held its Q1 earnings call. Read on for the main highlights of the call. Elite Pharmaceuticals’ latest earnings call struck a cautiously optimistic tone as management

The latest announcement is out from Elite Pharmaceuticals ( ($ELTP) ). Elite Pharmaceuticals reported that for the first quarter of fiscal 2027, ended June 30, 2026, consolidated revenue fell to

The latest announcement is out from Elite Pharmaceuticals ( ($ELTP) ). Elite Pharmaceuticals, Inc., a Northvale, N.J.-based specialty generics producer known for oral controlled-release drugs, will report financial results for

Elite Pharmaceuticals ( ($ELTP) ) just unveiled an announcement. On August 4, 2026, Elite Pharmaceuticals announced the commercial launch of its generic version of Requip XL, or ropinirole extended-release tablets,

Elite Pharmaceuticals (($ELTP)) has held its Q4 earnings call. Read on for the main highlights of the call. Elite Pharmaceuticals’ latest earnings call mixed hefty optimism with a dose of

An update from Elite Pharmaceuticals ( ($ELTP) ) is now available. For the fiscal year ended March 31, 2026, Elite Pharmaceuticals reported consolidated revenues of $148.9 million, representing a 77%
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 16, 2027TBA | $350.10M | ― | ― | -0.01 | 5.70 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.